ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1925

Goal Concordance in Rheumatoid Arthritis: Beyond Pain Reduction, Is There Agreement?

Jennifer Barton1,2, Shelia Markwardt2, Allison Schue1, Somnath Saha2,3 and Edward H. Yelin4, 1VA Portland Health Care System, Portland, OR, 2Oregon Health & Science University, Portland, OR, 3Medicine, VA Portland Health Care System, Portland, OR, 4Medicine/Rheumatology, University of California San Francisco, San Francisco, CA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Communication, patient engagement and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, October 22, 2018

Title: 4M104 ACR Abstract: Patient Outcomes, Preferences, & Attitudes I: Beliefs & Behaviors (1923–1928)

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Goal concordance between patients with chronic diseases and their clinicians has been linked to improved outcomes, but not explored in rheumatoid arthritis (RA). Our objective was to assess the extent to which RA patient goals for treatment are concordant with their rheumatologists and to identify correlates of goal concordance.

Methods: Patients meeting 2010 ACR criteria for RA and seen at least once in the prior 12 months at one of two rheumatology clinics (Veterans Affairs Hospital-based or university-based) were enrolled in a cross-sectional survey study. Both enrolled RA patients and their corresponding rheumatology fellow or attending who agreed to participate completed the RA goals measure (ranked top three goals for RA treatment out of eight possible choices) prior to the clinic visit. Patients then completed a longer survey on overall health, medications, demographics, health literacy, adherence and function. Primary outcome was goal concordance defined as the patient’s #1 goal being listed among any of the top three listed by the clinician. Differences in baseline patient characteristics by goal concordance were assessed using chi-square or Fisher’s exact tests for categorical variables and Mann-Whitney U tests for continuous variables.

Results: A total of 171 patient-clinician dyads were analyzed. Patients were 50% female, 15% Spanish-speaking, and 25% had limited health literacy. “Have less pain” was selected by both in 82% of dyads and “have fewer problems doing daily activities” by 61% (table). The proportion of dyads in which the clinician ranked the patient’s #1 goal among the top three was 80%. Given the overwhelming agreement around pain, the proportion of dyads with goal concordance after removing pain, fell to 36%. Goal concordance did not vary by age, gender, race/ethnicity, or health literacy. However, Spanish language was associated with a greater proportion being concordant with clinicians.  Of note, 27% of patients ranked “feel less tired” as one of their top three compared to only 6% of clinicians, 12% of patients ranked “improve mood” compared to 0% of clinicians, and 40% of clinicians ranked “Avoid side effects from medicine” compared with 14% of patients.

Conclusion: Among 171 RA patient and clinician dyads, the majority of patients shared their top goal with their clinicians’ top three, with “have less pain” as the most common goal. Beyond that shared goal, clinicians prioritized avoidance of side effects while patients ranked improved sleep, less fatigue, and improved mood. Tools to facilitate goal elicitation may help improve communication of what matters most to RA patients.

Table. Patient and clinician agreement on treatment goals for rheumatoid arthritis

Goal, N=171 pairs

Selected only by Patient,

N (%)

Selected only by Clinician,

N (%)

Not selected,

N (%)

Selected by both,

N (%) 1

Have less pain

11 (6.4)

17 (9.9)

3 (1.8)

140 (81.9)

Have fewer problems doing daily activities

6 (3.5)

54 (31.6)

6 (3.5)

105 (61.4)

Be able to work outside the home

31 (18.1)

35 (20.5)

93 (54.4)

12 (7.0)

Avoid side effects from medicine

23 (13.5)

69 (40.4)

36 (21.1)

43 (25.1)

Improve sleep

32 (18.7)

6 (3.5)

130 (76.0)

3 (1.8)

Feel less tired

46 (26.9)

10 (5.8)

102 (59.6)

13 (7.6)

Improve mood

21 (12.3)

–

150 (87.7)

–

Not affect ability to have children

7 (4.1)

–

163 (95.3)

1 (0.6)

Other

15 (8.8)

5 (2.9)

151 (88.3)

–

1 One of three goals selected for both patient and clinician

 


Disclosure: J. Barton, None; S. Markwardt, None; A. Schue, None; S. Saha, None; E. H. Yelin, None.

To cite this abstract in AMA style:

Barton J, Markwardt S, Schue A, Saha S, Yelin EH. Goal Concordance in Rheumatoid Arthritis: Beyond Pain Reduction, Is There Agreement? [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/goal-concordance-in-rheumatoid-arthritis-beyond-pain-reduction-is-there-agreement/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/goal-concordance-in-rheumatoid-arthritis-beyond-pain-reduction-is-there-agreement/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology